Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor.
about
Alterations of cAMP-dependent signaling in dystrophic skeletal muscleMuscle plasticity and β₂-adrenergic receptors: adaptive responses of β₂-adrenergic receptor expression to muscle hypertrophy and atrophyCreb coactivators direct anabolic responses and enhance performance of skeletal muscleAnabolic effects of a non-myotoxic dose of the beta2-adrenergic receptor agonist clenbuterol on rat plantaris muscleChanges in skeletal muscle gene expression following clenbuterol administration.The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditionsEffects of chronic administration of clenbuterol on contractile properties and calcium homeostasis in rat extensor digitorum longus muscle.Functional β-adrenoceptors are important for early muscle regeneration in mice through effects on myoblast proliferation and differentiationNervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesisBeta-adrenergic modulation of tremor and corticomuscular coherence in humans.Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol.Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training.Cancer cachexia, mechanism and treatmentSirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?Effects of intermittent weight-bearing and clenbuterol on disuse atrophy of rat hindlimb muscles.β-agonists selectively modulate proinflammatory gene expression in skeletal muscle cells via non-canonical nuclear crosstalk mechanisms.Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting.Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy.Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles.Dose-dependent apoptotic and necrotic myocyte death induced by the beta2-adrenergic receptor agonist, clenbuterolLong-Term Effects of Botulinum Toxin Complex Type A Injection on Mechano- and Metabo-Sensitive Afferent Fibers Originating from Gastrocnemius Muscle.cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regenerationUsing AAV vectors expressing the β2-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size.In vitro effects of Beta-2 agonists on skeletal muscle differentiation, hypertrophy, and atrophy.Control of cholangiocyte adaptive responses by visceral hormones and neuropeptidesRole of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.Beta-2 Adrenergic Receptor Genotype Influences Power Output in Healthy Subjects.Transforming growth factor betas are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a beta2 adrenergic agonist.Impaired structural and functional regeneration of skeletal muscles from β2-adrenoceptor knockout mice.A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy.Effects of formoterol on protein metabolism in myotubes during hyperthermia.Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles.Effects of combined stretching and clenbuterol on disuse atrophy in rat soleus muscle.Formoterol in the treatment of experimental cancer cachexia: effects on heart functionFormoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity.Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing ratsEffects of clenbuterol, a β₂-adrenergic agonist, on sizes of masseter, temporalis, digastric, and tongue muscles.Skeletal Muscle-specific G Protein-coupled Receptor Kinase 2 Ablation Alters Isolated Skeletal Muscle Mechanics and Enhances Clenbuterol-stimulated Hypertrophy.
P2860
Q27003221-71A70AA0-C9F0-45E9-AC87-EEB5C8111731Q27016049-CDDE306A-F469-49AA-B731-B4CB47EF76DBQ28507328-475CE2D4-45EF-474E-8C4D-354D0A58E0CDQ28566103-1B4C4A07-EB10-4203-BB5C-868B513FCF9CQ33267204-651641B2-7B7F-423D-A7A6-498CA3AD124DQ33751732-314299F7-FD5B-4F89-8B9D-63FE7C973215Q33804521-F12FC65B-06C6-448F-9202-4E495C81F0FFQ33817082-471588E9-6D01-46BD-9E2F-37203C25781BQ33855954-A6B9BAAB-AF49-495C-A43D-B5FB1AC4A62CQ33866778-2DAD10F7-D302-4F13-90DC-C6CAF2B1584FQ34489866-09570301-936C-44A4-917B-36FC3EFF1124Q34577070-51F664E6-170D-474D-9E66-43853F094ACEQ34603843-801706A2-EBC5-40BC-8F9B-A2C9355BB745Q34669440-DA54EA5D-9520-4AD5-ADA1-01C206A7D63AQ34716943-EA038D84-FFFE-4536-A05F-9A0AA7E5E882Q35047104-02AA8704-B066-4155-9B71-AA541580950AQ35113012-AFE76432-33C5-4FBE-9B2D-4431C7F19F70Q35545370-D92CD2D9-8756-4CB7-B0A3-B08DE100BC40Q35687767-E8889086-300F-4488-B1BC-26C0047F731EQ35689555-C085FE8D-EE54-4C4F-9C33-3D00189206DCQ35695495-2D928E3D-B3D2-4B9C-8718-FA86240A59CFQ35814877-6D49B9C1-D19C-4126-ADFB-0A260E8E10ECQ36114861-249D4A59-2A0A-4D4A-88FB-BF16567678E3Q36682199-52118A21-17C2-4BA0-A1D8-012295F861E4Q36834807-575A332C-F11B-4D74-938B-9FA6B8E553B5Q37067699-DD0DA60B-6EF4-4F45-8BA2-A564D0EC29BBQ37129351-CE4A8C8F-EB3A-4EDA-BF8D-800CA60C9413Q37805634-36C043F0-A244-4F89-9C84-7EFD8E606DB3Q38756401-EE72A052-E9A0-49BE-A92E-0F2D2278D72CQ38756829-795ECC39-644F-414B-84E9-64450785E651Q39174364-919BF173-5991-47E4-97C3-06E976093412Q39218137-7F31442B-FE9A-4DAB-9542-0D6D855AB51DQ39604824-D7F05E84-1865-474D-B0D9-4E52D5E286E5Q40199686-C29F2F2A-4EF9-4BBC-B7E8-3EF244B1990AQ41189517-D53BBCCB-9ACA-4C40-A10F-F98A7A5919BCQ42062172-4739B283-B6BE-4A87-B234-90A6FEC87E67Q42132692-6DE1CC3F-E787-4FE3-A83E-A9FE5ED15655Q42180586-A58F6E4F-9C4F-453A-BD1C-D881693F2BF4Q42274415-18D27C02-D1D7-425B-8248-1C43C9B383EDQ42383194-69A08998-ECD3-4D1F-A5EC-FC4948BDD595
P2860
Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Skeletal muscle hypertrophy an ...... the beta2-adrenergic receptor.
@en
Skeletal muscle hypertrophy an ...... the beta2-adrenergic receptor.
@nl
type
label
Skeletal muscle hypertrophy an ...... the beta2-adrenergic receptor.
@en
Skeletal muscle hypertrophy an ...... the beta2-adrenergic receptor.
@nl
prefLabel
Skeletal muscle hypertrophy an ...... the beta2-adrenergic receptor.
@en
Skeletal muscle hypertrophy an ...... the beta2-adrenergic receptor.
@nl
P2093
P2860
P356
P1433
P1476
Skeletal muscle hypertrophy an ...... the beta2-adrenergic receptor.
@en
P2093
David B Cody
Karen M B Hodge
Richard T Hinkle
Robert J Isfort
Russell J Sheldon
P2860
P304
P356
10.1002/MUS.10092
P577
2002-05-01T00:00:00Z